Imaging features of COVID-19 (LifeBridge Health)

Imaging features of COVID-19 (LifeBridge Health)

Critical Care Week 2

Critical Care Week 2

Cardiovascular system anatomy and physiology
Coronary circulation
Abnormal heart sounds
ECG cardiac hypertrophy and enlargement
ECG cardiac infarction and ischemia
Atrial flutter
Atrial fibrillation
Supraventricular arrhythmias: Pathology review
Heart blocks: Pathology review
Class III antiarrhythmics: Potassium channel blockers
Class II antiarrhythmics: Beta blockers
Class IV antiarrhythmics: Calcium channel blockers and others
Calcium channel blockers
Apnea, hypoventilation and pulmonary hypertension: Pathology review
Atrial septal defect
Premature atrial contraction
Atrioventricular nodal reentrant tachycardia (AVNRT)
Ventricular tachycardia
Bronchodilators: Beta 2-agonists and muscarinic antagonists
Anatomic and physiologic dead space
Ventricular arrhythmias: Pathology review
Wolff-Parkinson-White syndrome
Long QT syndrome and Torsade de pointes
Myocarditis
Adrenergic antagonists: Alpha blockers
Ventricular fibrillation
Pericardial disease: Pathology review
Action potentials in pacemaker cells
Cardiomyopathies: Clinical
Syncope: Clinical
Premature ventricular contraction
Heart failure: Clinical
Ventricular septal defect
Cardiomyopathies: Pathology review
Heart failure: Pathology review
Pulmonary hypertension
Acute respiratory distress syndrome
Aortic aneurysms and dissections: Clinical
Peripheral vascular disease: Clinical
Valvular heart disease: Clinical
Pericardial disease: Clinical
Pulmonary embolism
Restrictive lung diseases
Pneumothorax
Chronic obstructive pulmonary disease (COPD): Clinical
Obstructive lung diseases: Pathology review
Chronic bronchitis
Coronary artery disease: Clinical
Diffuse parenchymal lung disease: Clinical
Restrictive lung diseases: Pathology review
Lung volumes and capacities
Compliance of lungs and chest wall
Gas exchange in the lungs, blood and tissues
Anatomy of the lungs and tracheobronchial tree
Pneumonia
Acute respiratory distress syndrome: Clinical
Respiratory alkalosis
Respiratory acidosis
Respiratory system anatomy and physiology
Pneumonia: Pathology review
Pneumonia: Clinical
Klebsiella pneumoniae
Chlamydia pneumoniae
Mycoplasma pneumoniae
Streptococcus pneumoniae
Pleural effusion: Clinical
Legionella pneumophila (Legionnaires disease and Pontiac fever)
Imaging features of COVID-19 (LifeBridge Health)
Pseudomonas aeruginosa
Adenovirus
Asthma
Rheumatic heart disease
Deep vein thrombosis and pulmonary embolism: Pathology review
Cardiac conduction velocity
Cardiac tamponade
Cor pulmonale
Idiopathic pulmonary fibrosis
Diffusion-limited and perfusion-limited gas exchange
Ventilation-perfusion ratios and V/Q mismatch
Oxygen-hemoglobin dissociation curve
Oxygen binding capacity and oxygen content
Hypoxia
Pulmonary edema
Emphysema
Respiratory distress syndrome: Pathology review
Endocarditis
Angina pectoris
Stable angina
Unstable angina
Myocardial infarction
Prinzmetal angina
Peripheral artery disease
Aortic dissection
Aneurysms
Hypotension
Pulseless electrical activity
Mitral valve disease
Heart failure
Endocarditis: Pathology review
Infective endocarditis: Clinical
Restrictive cardiomyopathy
Valvular heart disease: Pathology review
Pulmonary valve disease
Aortic dissections and aneurysms: Pathology review
Saccular aneurysm
Atherosclerosis and arteriosclerosis: Pathology review
Marfan syndrome
Peripheral artery disease: Pathology review
Metabolic acidosis
Metabolic and respiratory acidosis: Clinical
Metabolic alkalosis
Metabolic and respiratory alkalosis: Clinical
Acid-base disturbances: Pathology review
Acid-base map and compensatory mechanisms
Upper respiratory tract infection
Clinical Skills: Respiratory rate assessment
Lung cancer: Clinical
Hypertension: Clinical
Class I antiarrhythmics: Sodium channel blockers
Regulation of pulmonary blood flow
Ventilation
Clinical Skills: Mechanical ventilation - conventional ventilators
Lung cancer
Standards of care for COVID-19 patients
Coronavirus disease 19 (COVID-19)
Mycobacterium tuberculosis (Tuberculosis)
Tuberculosis: Pathology review
Zones of pulmonary blood flow
Carbon dioxide transport in blood
Clinical Skills: BiPAP and CPAP
Bundle branch block
Adrenergic antagonists: Beta blockers

Transcript

Watch video only

As of March 16th, so in just the first three months of the outbreak, there have been 167,511 cases of COVID-19 and 6,606 deaths, working out to a mortality rate of 3.9%.

On top of that, every case of COVID-19, leads to roughly 2.3 new cases, meaning that the outbreak is still spreading.

Many countries have been affected, and there are numerous cases of community spread, meaning that individuals are getting sick without being around any sick contacts or having traveled to outbreak areas.

In that context, healthcare workers need diagnostic tools to investigate cases of potential COVID-19 that are both sensitive and specific.

The gold standard for diagnosis of COVID-19 is RT-PCR, or reverse transcription polymerase chain reaction.

In the early days of the epidemic in China RT-PCR was only 30 to 70% sensitive whereas Chest CT was reportedly much more sensitive in that context.

However, more recent data from the US labs at the University of Washington suggests that second generation COVID RT-PCR tests are faring much better, with 95%+ sensitivity.

Despite its usefulness in the early days of the epidemic in China, Chest CT findings are no longer part of the diagnostic criteria for COVID.

There are still clearly issues with access to RT-PCR and related wait times in the US and elsewhere.

Nevertheless, over the past several weeks, several major US radiology societies have come out with statements making it clear that CT should be used sparingly in COVID and only when it will impact management.

However, because there will be certain cases when imaging is indicated, as well as patients imaged for other reasons whose scans reveal findings potentially suggestive of COVID, it is essential that healthcare providers be familiar with the imaging features of the infection.

Typically, when a patient has symptoms of COVID-19, like fever, cough, or shortness of breath, they may get a chest X-ray.

The most common abnormal finding is “ground glass” opacities, meaning that some portions of the lungs look like a “hazy” shade of gray instead of being black with fine white lung markings for blood vessels.

It looks a bit like frosted glass, like a window in the wintertime.

It is important to note, however, that chest X-rays are not very sensitive for COVID-19 and can yield false negatives.

Now compared to chest X-rays, chest CT gives a much more detailed view.

The most common CT finding in COVID-19 are those ground-glass opacities scattered throughout the lungs.

They represent tiny air-sacs or alveoli getting filled with fluid, and turning a shade of grey on a CT scan.

In severe or more advanced infections, more and more fluid will accumulate in the lobes of the lungs, so the ground glass appearance will progress to a solid white “consolidation.”

Finally, there’s a finding called the “crazy paving” pattern due to swelling of the interstitial space along the walls of the lung lobules.

This makes the walls look thicker, like white lines against the hazy, ground glass background.